WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512) Other
Market cap
¥11.8B
P/E ratio
51.4x
Wakamoto Pharmaceutical manufactures branded drugs, generic medicines, and health products like Koryoku Wakamoto for healthcare providers and consumers in Japan and internationally.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Return on Assets | - | - | - | - | 0.1 | 0.5 | 0.7 | -1 | -0.6 | -0.3 | 1.6 | 0.9 | 2 | 0.6 | 1.4 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 403 | 390 | 366 | 353 | 362 | 363 | 339 | 334 | 315 | 306 | 300 | 292 | 274 | 286 | - |
| Total payout ratio | - | - | - | 131.1 | 522.1 | 112.6 | 85.2 | -57.2 | -0 | -0.1 | 0.2 | 0.4 | 95.4 | 160.5 | 45.8 |